The firm is currently evaluating the fairness of the sale of Element Solutions, Inc. (NYSE: ESI) to Solstice Advanced Materials, Inc. Under the proposed terms, Element Solutions shareholders are set to receive $10.00 in cash plus 0.500 shares of Solstice common stock, ultimately holding approximately 44% of the combined entity. Simultaneously, the firm is investigating the $85.00-per-share cash acquisition of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) by Vertex Pharmaceuticals Incorporated.
In section Releases
Monteverde & Associates Launches Investigations Into Four Corporate Mergers
New York-based law firm Monteverde & Associates PC has initiated formal investigations into a series of high-profile corporate acquisitions. Attorney Juan Monteverde is scrutinizing the terms of proposed deals involving Element Solutions, Crinetics Pharmaceuticals, Solstice Advanced Materials, and Patrick Industries to protect shareholder interests during these pending ownership transitions.
Additional inquiries target the merger between Solstice Advanced Materials, Inc. (NASDAQ: SOLS) and Element Solutions, alongside the deal between Patrick Industries, Inc. (NASDAQ: PATK) and LCI Industries. In the latter transaction, Patrick shareholders are expected to retain a 52% stake in the resulting company. Investors holding common stock in these entities are encouraged to contact Juan Monteverde at jmonteverde@monteverdelaw.com or (212) 971-1341 to discuss potential concerns regarding these transactions.
Comments (0)
No comments yet. Be the first!